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Abstract: 
The results of biochemical analyses in specimens obtained postmortem may aid death 
investigation when diabetic and alcoholic ketoacidosis is suspected, when death may have been 
the result of drowning, anaphylaxis, or involved a prolonged stress response such as hypothermia, 
and in the diagnosis of disease processes such as inflammation, early myocardial infarction, or 
sepsis. There is often cross-over with different disciplines, in particular with clinical and forensic 
toxicology, since some endogenous substances such as sodium chloride, potassium chloride, and 
insulin can be used as poisons. The interpretation of results is often complicated because of the 
likelihood of postmortem change in analyte concentration or activity, and proper interpretation must 
take into account all the available evidence. The unpredictability of postmortem changes means 
that use of biochemical measurements in time of death estimation has little value. 
The use of vitreous humour is beneficial for many analytes as the eye is in a physically 
protected environment, this medium may be less affected by autolysis or microbial metabolism 
than blood, and the assays can be performed with due precaution using standard clinical chemistry 
analysers. However, interpretation of results may not be straightforward because (i) defined 
reference ranges in life are often lacking, (ii) there is a dearth of knowledge regarding, for example, 
the speed of equilibration of many analytes between blood, vitreous humour, and other fluids that 
may be sampled, and (iii) the effects of post-mortem change are difficult to quantify because of the 
lack of control data. A major limitation is that postmortem vitreous glucose measurements are of no 
help in diagnosing antemortem hypoglycaemia. 
 
 
Keywords: ‘forensic biochemistry’, ‘postmortem’, ‘death investigation’, ‘vitreous humour’, ‘glucose’, 
‘potassium’, ‘alternative matrices’, ‘ketoacidosis’, ‘drowning’, ‘anaphylaxis’, ‘hypothermia’ 
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Introduction 
Postmortem biochemistry1 has a role in investigating some apparently natural deaths, including 
diabetic- and alcoholic ketoacidosis-related deaths, anaphylaxis-related deaths, deaths that may 
have involved prolonged stress response such as hypothermia, and in the diagnosis of disease 
processes such as early myocardial infarction. There is also clearly much overlap with clinical and 
forensic toxicology in that some endogenous substances can be used as poisons. Sodium 
chloride, potassium chloride, and insulin are obvious examples. Indeed, in some instances 
suspicion of poisoning may be aroused by abnormal biochemical results (Table 1). 
Postmortem biochemistry has been an active area of research for many years. Detection of 
acetone and measurement of β-hydroxybutyrate (3-hydroxybutyrate; BHB) in blood, or in vitreous 
humour, urine, pericardial fluid, or cerebrospinal fluid (CSF) may be valuable in the diagnosis of 
alcohol- or diabetes-related deaths, for example [1]. Likewise, measurement of D-glucose [2], and 
of urea and creatinine in vitreous humour and other specimens [3], may give information on the 
presence of hyperglycaemia and of renal impairment, respectively, before death. Vitreous humour 
is an important specimen in this context as in life the concentrations of low molecular weight, non-
protein bound solutes such as ethanol and electrolytes in blood equilibrate with the respective 
concentrations in vitreous humour. However, at present few other measurements are undertaken 
routinely (Table 2), in part because the necessary samples, not only vitreous humour, but also 
CSF, and pericardial and synovial fluids (Table 3), may not be collected. The aim of this review is 
to summarise considerations important in undertaking postmortem biochemical analyses, including 
sample collection and the interpretation of results. In all cases of course the results can only be 
properly interpreted in the light of all the available information as to the case under investigation 
[2].  
In death investigations, although specimens collected postmortem are all that are usually 
available for biochemical and toxicological analysis, in general it is information on analyte 
concentration or other physiological parameter prior to, or at the time of, death that is required. 
Gradients that are maintained by active processes in life such as that between intra- and extra-
cellular potassium begin to break down soon after the occurrence of hypoxic or anoxic damage. 
Thus, the possibility of both terminal and postmortem change has to be evaluated when 
interpreting results. Since most deaths that become the subject of further investigation occur 
outside hospital, it may be some days before a body is found. Therefore blood samples are often 
haemolysed, there is the possibility of sample contamination during collection, and the likelihood of 
other changes such as loss of labile analytes (for example glucose, insulin) is high. It should be 
remembered that most clinical reference values are established for plasma or serum, and not 
haemolysed whole blood even for stable analytes such as many drugs. Moreover, since samples 
                                               
1
 Postmortem biochemistry is sometimes termed thanatochemistry (from the Greek θάνατος, Thanatos, the 
personification of death in Greek mythology) 
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such as vitreous humour are, for practical purposes, rarely available during life except from 
laboratory animals, reference ranges are by definition difficult to establish. Method validation is 
also compromised by this same lack of reference material. Furthermore, the time needed for 
analyte equilibration between plasma and, for example, vitreous humour during life remains 
unknown.  
Use of Vitreous Humour 
The above considerations notwithstanding, vitreous humour is preferred to blood for most 
postmortem biochemistry (Table 4) since it is thought far less susceptible to autolytic change, is 
less likely to be subject to postmortem contamination by diffusion of microbes or of drugs or other 
poisons that may be present at high concentration in the thorax or abdomen at death, and lies 
within the relatively protected environment of the eye socket [25,26]. A further practical point is that 
the sample if uncontaminated with blood is amenable to analysis using standard clinical chemistry 
systems and as such the cost of routine measurements (Table 4) is minimal [2]. Note however that 
vitreous humour is viscous, hence may require pre-treatment such as centrifugation, heating, 
dilution, or addition of hyaluronidase to facilitate accurate pipetting [16,27-28]. There is also the 
likelihood of loss of water from the eye with time since death and body storage conditions, leading 
to not only increased vitreous humour viscosity, but also increased analyte concentrations.  
Vitreous samples should be collected without preservative unless for a specific requirement 
such as ethanol measurement since even dipotassium EDTA contains sufficient sodium to 
invalidate vitreous sodium measurement. Vitreous humour may not be available if the body has 
suffered severe trauma, and the possibility of concurrent vitreous disease confounding the results 
must be remembered [29]. In cases where bodies have been immersed in water then either dilution 
(fresh water), or concentration (salt water) as well as microbial contamination are possible. 
Synovial fluid may represent an alternative if vitreous humour is not available [30]. 
When collecting vitreous humour, ideally both eyes should be sampled independently and 
the results reported separately, although this may not always be possible, for example in the case 
of very young children. Potassium concentrations have been said to differ by up to 2.34 mmol/L 
between the two eyes in samples from non-putrefied bodies [32]. However, these and other 
reported differences may be simply due to problems in sample collection and handling [33]. More 
importantly, after death potassium quickly leaks from the retina and hence vitreous potassium is 
not a reliable indicator of antemortem plasma potassium and is of minimal value in the diagnosis of 
exogenous potassium administration. Specimen contamination with retinal cells is also a 
recognised source of falsely raised vitreous potassium concentrations [29]. Hence aspiration must 
be as gentle as possible to minimise the risk of contamination with retinal fragments. Measurement 
of uric acid in vitreous humour may offer a criterion for identifying blood contamination before 
colouration of the fluid is apparent [34].  
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Vitreous sodium and chloride concentrations may fall after death at rates of up to 1 mmol 
L-1 h-1, whereas potassium increases at a rate of 0.14–0.19 mmol L-1 h-1. Nevertheless, if the 
potassium concentration is <15 mmol/L, then the sodium and chloride concentrations are thought 
likely to reflect the situation at death. Urea and creatinine, on the other hand, are relatively stable in 
postmortem specimens such as vitreous humour and pericardial fluid [3]. If vitreous sodium, 
chloride, and urea are >155, >115, and >10 mmol/L, respectively, this may indicate antemortem 
dehydration. If the urea concentration is >20 mmol/L and creatinine >200 µmol/L with sodium and 
chloride being within the normally accepted range, this indicates uraemia may have been present 
before death depending on other factors (age, sex, muscle mass, etc.). An especially difficult area 
is attempting to distinguish between hypernatraemic dehydration and sodium chloride poisoning in 
infants and children and due caution must be exercised in interpreting results [35]. 
Specific Diagnostic Problems 
1. Anaphylaxis/anaphylactoid reactions 
Death from anaphylaxis is rare (0.12 to 1.06 deaths per million person-years) and more likely in 
older individuals in the case of drug- and Hymenoptera-induced anaphylaxis [36]. Drug-induced 
anaphylaxis is a common cause of anaphylaxis and a leading cause of fatal anaphylaxis. 
Antibiotics, radiocontrast media, and nonsteroidal anti-inflammatory drugs are commonly 
implicated compounds [37]. Mast-cell tryptase is an indicator of mast-cell activation [38]. Sampling 
from the femoral vein is recommended postmortem as aggressive attempts at resuscitation and 
defibrillation can release tryptase from the heart, but this is thought not to affect femoral blood 
tryptase concentrations [39]. Measurement of blood chymase [40] and of blood histamine and 
blood diamine oxidase [41] has also been suggested in this context. Although a raised serum or 
plasma tryptase can supply important supporting evidence in the diagnosis of anaphylaxis [38,42], 
it cannot be used as the sole criterion for the postmortem diagnosis of anaphylaxis even if an 
appropriate sample is available because elevated tryptase concentrations have also been reported 
in deaths unrelated to anaphylaxis [43-48].  
Immunoglobulin E (Ig ) measurement has been suggested as a confirmatory test if serum 
tryptase is raised. Specific IgEs produced in response to venoms and to many foods, including 
those commonly causing anaphylaxis, can be measured. IgEs produced in response to some 
penicillins and a thiocholine epitope that in many cases cross-reacts with muscle relaxants, which 
are possibly the most common cause of fatal iatrogenic anaphylaxis, can also be assayed [49]. 
However, IgE elevation can only be assessed if the offending allergen is either known, or 
suspected. As many deaths are unwitnessed and possible allergens go unrecognised, the utility of 
IgE measurement is limited. A screening approach, utilizing an array of commonly encountered 
allergens, has been suggested [50]. However, there is wide inter-individual variability in serum IgE 
concentration. Serum IgE may be either seasonally, or chronically elevated in the absence of 
disease, and thus establishing ‘normal’ and ‘elevated’ IgE concentrations is difficult [41]. Increased 
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IgE concentrations have also been reported in association with trauma and with sepsis [51]. IgE 
remains relatively unused, and further studies are required to confirm its postmortem stability [50]. 
2. Disorders of Glucose Metabolism 
Lundquist and Osterlin [52] assayed D-glucose in blood and vitreous humour from three patient 
groups undergoing vitrectomy: those classified as nondiabetic (ND), those with Type 1 diabetes 
(diabetes mellitus Type 1, T1D), and patients with Type 2 diabetes (diabetes mellitus Type 2, T2D). 
In the ND group the vitreous glucose concentration (3.5 ± 1.8 mmol/L) was always lower than the 
blood glucose (9.1 ± 3.5 mmol/L). In the diabetic groups the vitreous glucose was generally lower 
than the blood glucose, but was generally higher (T1D 9.4 ± 3.3 mmol/L, T2D 7.2 ± 3.9 mmol/L) 
than in the ND group, and in 15 specimens exceeded 11 mmol/L. However, blood and vitreous 
humour glucose concentrations generally fall rapidly after death and are thus an unreliable guide to 
antemortem glucose concentration. However, any measurable glucose suggests antemortem 
hyperglycaemia. Collecting samples into fluoride preservative does not make any difference to 
vitreous glucose concentrations [16]. 
 D-Glucose undergoes anaerobic glycolysis to L-lactate, and some investigators have 
suggested that measuring the sum of vitreous humour glucose and lactate may give a better 
estimation of the glucose concentration at the time of death [19,53-55]. However, vitreous lactate 
may continue to increase for several days after death and interpretation in relation to vitreous 
glucose is equivocal at best [56]. Some drugs that are themselves unstable in biological systems, 
for example ethanol and insulin, may cause fatal hypoglycaemia, hence compounding the 
difficulties that may be encountered in establishing a cause of death. A further complication is that 
death may be accompanied by attempted resuscitation and agonal processes resulting in 
administration or secretion of catecholamines, leading to the breakdown of glycogen and formation 
of glucose in a counter-balancing phenomenon [57]. 
An elevated postmortem blood haemoglobin A1c (HbA1c) concentration might indicate poor 
glucose control during life [58], but note that this measurement is unreliable in 
decomposed/degraded samples. Measurement of fructosamine postmortem has been suggested 
as an indicator for confirming the presence of antemortem hyperglycaemia [59], but is not 
commonly measured. Note that fructosamine can be measured in postmortem blood and in 
vitreous humour, but HbA1c cannot be measured in vitreous humour as this matrix is not 
vascularized [16].  
In patients with T1D the presence of acetone in blood, urine, and/or vitreous humour may 
indicate the occurrence of diabetic ketoacidosis (DKA) prior to death especially if considered 
together with the blood, urine or vitreous BHB concentration [60-62]. Detection of acetoacetate is 
not normally possible postmortem since the prevailing acidic conditions favour transformation to 
acetate [16]. BHB concentrations > 2.4 mmol/L (> 250 mg/L) are thought to be pathologically 
significant [63]. In contrast, hyperosmolar hyperglycaemic syndrome [HHS, also known as 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Postmortem Biochemistry           Page 6 
hyperosmolar non-ketotic hyperglycaemia (HONK)] normally occurs in patients with T2D who are 
often nursing home residents aged 55–70 yr. Most who develop HHS do so over days or weeks 
and have polyuria, polydipsia, and a progressive decline in consciousness [64]. The most common 
clinical presentation is said to be altered perception of surroundings. HHS patients do not usually 
produce acetone or other biochemical markers that can be tested for postmortem, and the only 
clue as to the presence of hyperglycaemia in life may be a raised vitreous glucose concentration 
(Figure 1). 
Measurement of ketones in blood or vitreous humour is also recommended in unexplained 
deaths in chronic alcoholics as well as in diabetics [65]. Prolonged use of alcohol and poor nutrition 
(common in chronic alcoholics) promote the accumulation of ketones (acetone, butanone) and 
BHB, and often elevated blood ketone concentrations (acetone > 20 mg/L, BHB > 2.5 mmol/L) are 
the only notable postmortem findings. It has been suggested that blood acetone concentrations > 
90 mg/L can indicate a fatal ketoacidotic coma, but interpretation of an acetone concentration 
alone is unwise as endogenous acetone accounts for only 2 % of total ketone bodies and there are 
extrinsic sources of acetone such as ingestion of either acetone itself, or of 2-propanol [66].  
Blood ethanol measurement postmortem may aid in distinguishing alcoholic ketoacidosis 
from starvation or diabetic ketoacidosis. However postmortem production, or indeed loss, of 
ethanol can complicate interpretation of results. There is said to be a lower likelihood of ethanol 
production by microbes in vitreous humour as compared to blood. In this context, it has been 
suggested that measurement of ethyl glucuronide (EtG) and of ethyl sulfate (EtS) in vitreous 
humour may help distinguish between antemortem ethanol ingestion and postmortem ethanol 
production [12,13]. EtG and EtS are reported to have high sensitivity and specificity in corpses 
without signs of putrefaction. EtS may be more stable than EtG in putrefied corpses and 
measurement of these compounds in urine rather than in vitreous humour may also help as urinary 
concentrations will usually be higher [13,67,68]. 
An additional complication when diagnosing alcoholic ketoacidosis is that some 50 % of all 
alcoholics die with a negligible blood alcohol concentration [69]. In these cases, use of chronic 
alcohol markers, in particular carbohydrate-deficient transferrin (CDT), may aid a diagnosis. 
Measurement of CDT using capillary zone electrophoresis or high-performance liquid 
chromatography is recommended due to the low specificity of some immunoassay methods. CDT 
is reported to be stable in postmortem blood for up to 7 days after death, and does not appear to 
be subject to redistribution after death [7]. However, haemolysed samples are unsuitable for CDT 
analysis at present, and thus investigation into measurement of CDT in other matrices less prone 
to postmortem change is needed. Preliminary studies measuring CDT in vitreous humour have 
been conducted [6,70,71], but further research is required.   
 Diagnosis of hypoglycaemia may involve detection of drugs that may cause hypoglycaemia 
such as insulin or ethanol. Calculation of the insulin to C-peptide ratio in blood has been used to 
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differentiate endogenous production from exogenous administration of insulin, which lacks C-
peptide [72]. However, murder or suicide by means of insulin, even if suspected, is difficult to 
prove. Immunohistochemical demonstration or measurement of an elevated insulin concentration 
in tissue around an injection site compared to a control site can support the diagnosis [73]. 
Haemolysed postmortem blood is not the ideal matrix for insulin measurement since 
release of insulin-degrading enzyme (EC 3.4.24.56) from erythrocytes may give falsely low insulin 
concentrations [74]. On the other hand, haemolysis could in theory increase plasma insulin and 
hence falsely elevated insulin concentrations could also be encountered. The use of vitreous 
humour, bile, and cerebrospinal and pericardial fluids as alternative matrices for insulin 
measurement has been suggested [75,76]. Finally, analytical methods for insulin used clinically 
may give different results with the same sample. Many different insulin analogues are available 
and different analogues may cross-react differently to the antibody used in an immunoassay. There 
may also be interference from endogenous anti-insulin antibodies. A two-fold variance in insulin 
measurements between different commercial immunoassays and between different laboratories 
using the same immunoassay has been reported [77,78]. Thus, interpretation of postmortem 
insulin:C-peptide results must always be performed with due caution [73].  
3. Drowning 
Establishing drowning as a cause of death can be difficult. Evidence showing aspiration of the 
immersion medium and the subsequent mechanism of death should be forthcoming [79]. Lung 
weight and diatom analysis help assess the cause of death. However, the use of biochemical 
markers has been suggested as an additional parameter of study because of the lack of specific 
morphological findings associated with lung weight in drowning and contamination problems 
associated with diatom detection, e.g. water filtered through diatomaceous earth. 
Immunohistochemical measurement of increased pulmonary surfactant-associated protein A (SP-
A) concentration has been used as another confirmatory test, but the test is non-specific with 
increased concentration noted in cases of acute myocardial infarction (AMI) [80]. This lack of 
specificity limits the use of SP-A in diagnosis of drowning, but it remains a good marker of alveolar 
injury [81-83].   
  Haemodilution, as suggested by lowered vitreous sodium concentrations, is likely in victims 
of fresh water drowning, but not in those drowned in salt water where raised vitreous sodium may 
be expected [80,82]. Thus concentrations of ethanol, drugs or other analytes measured in the 
blood of victims of fresh water drowning may be misleadingly low. Conversely, 
haemoconcentration is likely if a cadaver has been dehydrated, for example by heat or by 
mummification. In all such cases measurement of blood haemoglobin may give an estimate of the 
magnitude of haemodilution/concentration if it has not been degraded by heat or by prolonged 
storage. 
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It was suggested that haemodilution in fresh water drowning produces a lower chloride 
concentration in left heart blood as compared to right heart blood, while in salt water drowning 
haemoconcentration and chloride ion absorption was said to produce the opposite result. It was 
also suggested that high concentrations of magnesium in left heart blood compared to right heart 
blood may reflect magnesium absorption from salt water [80]. However, there is no clear 
consensus as to the predictive value of such measures in blood or in pericardial fluid, for example 
[79]. 
More recently, trace element analysis, in particular measurement of strontium, has been 
proposed as an aid to diagnose drowning [84]. It has been postulated that transfer of strontium 
from water into blood causes raises the strontium concentration in left ventricular blood, which can 
either be interpreted in its own right, or as a ratio to the strontium concentration in right ventricular 
blood [85]. In the case of freshwater drowning, the concentration of strontium in the water must be 
higher than the plasma concentration for the investigation to be of diagnostic utility [86].  
Measurement of chlorine and bromine in liquid taken from the sphenoid sinus has also been 
suggested as a means of distinguishing between freshwater and seawater drowning victims [87]. 
4. Hypothermia/Hyperthermia 
Cold may be a significant factor in a death, but there are no specific biochemical markers that can 
be used to confirm a diagnosis of fatal hypothermia [88]. Diagnosis of death due to hypothermia is 
usually reliant on signs such as frost-erythema and Wischnewski’s spots, which are present in 
approximately two thirds of cases [89]. Biochemical indications of antemortem cold stress may 
include raised urinary adrenaline and noradrenaline, and/or metanephrine (metadrenaline) 
concentrations [4,90,91]. Urinary catecholamine measurement has been recommended in 
preference to blood analysis because of postmortem catecholamine release from sympathetic 
nerve endings and the adrenal glands [92], but catecholamine instability is a major issue as with 
clinical catecholamine measurement and of course urine may not be available postmortem. 
Vitreous humour glucose and ketones such as acetone may also be elevated, and in persistent 
hypothermia there may be electrolyte disturbances and metabolic acidosis [93]. A role for 
chromogranin A measurement in the postmortem diagnosis of hypothermia has been postulated 
because it is co-secreted with catecholamines [9]. The possible role of analytes such as adreno-
corticotropic hormone and thyroid stimulating hormone have also been investigated, but have 
found limited use [89,94]. 
Measurement of dopamine, adrenaline, and noradrenaline in postmortem blood has also 
been claimed to be suggestive of hyperthermia [95]. However, as with attempts to assess 
hypothermia, similar practical issues, not least the marked instability of catecholamines in 
biological samples, complicate attempts to assess hyperthermia from postmortem measurements. 
Fatal hyperthermia (heat stroke) often involves multiple organ dysfunction, and may include 
skeletal muscle damage without marked inflammatory responses [95]. Myoglobin has been 
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suggested as a possible indicator of antemortem massive skeletal muscle damage, with 
concentrations >330 and >1 mg/L observed in serum and in blood-contamination free urine, 
respectively, in fatal hyperthermia [20]. However, blood myoglobin may increase after death hence 
sampling should be within 48 h of death and of course the availability of serum postmortem and the 
instability of myoglobin in urine [96] are also issues. The isolated elevation of serum creatinine has 
likewise been suggested as a diagnostic marker for heat stroke [97], but again is in the main 
impractical.  
5. Inflammation 
Blood CRP concentration peaks within six hours of a stimulus and CRP is stable in postmortem 
samples. Liver is said to be a good alternative specimen if blood is not available [98-100], but there 
are practical issues here in using standard clinical chemistry autoanalysers for tissue analysis. 
Interpretation of results can be difficult, however, as there are many causes of a raised blood CRP 
in addition to inflammation (Table 2). 
6. Myocardial Infarction  
It may be difficult to diagnose AMI from anatomical and histological investigation alone, particularly 
if there was only a short survival period. The measurement of markers of heart muscle damage 
(e.g. myoglobin, creatine kinase, troponin) as an adjunct to searching for evidence of microscopic 
changes in samples of myocardium has thus been investigated. 
 Cardiac troponin I (cTnI) has high specificity as a marker for myocardial damage as it is 
found exclusively in cardiac muscle, unlike other markers such as myoglobin and the MB 
isoenzyme of creatine kinase (CK-MB). Measurement of cTnI in pericardial fluid and in serum 
obtained postmortem has shown that cTnI is significantly elevated in the pericardial fluid of 
individuals who have experienced AMI when compared to controls [101]. Cardiac troponin T (cTnT) 
is also used as a marker of cardiac injury and a raised cTnT concentration in postmortem blood 
may be associated with individuals who have suffered AMI and after death from electrocution 
owing to passage of an electric current through the heart damaging the myocardium [102]. Finally, 
measurement of cTnT and cTnI in CSF has been assessed and could be of use in investigating the 
progress and duration of myocardial damage [103], but assay validation is an issue here since 
these assays are normally only validated in blood. 
CK-MB activity has been said to be independent of the morphological severity of 
myocardial damage and not to be raised significantly after acute or recurrent myocardial infarction 
[22], although this assay is no longer widely available after being superseded by other markers of 
myocardial damage. Elevated CK-MB activity has been reported after asphyxia, carbon monoxide 
poisoning, and metamfetamine abuse. CK-MB may be used as a marker of persistent hypoxic 
myocardial damage before death, whereas cTnT and cTnI are said to be more useful in assessing 
the progress and duration of myocardial damage [104]. 
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7. Time of Death Estimation 
Attempts to employ the rate of rise of vitreous humour potassium in order to calculate the time of 
death have largely been abandoned because of the inherent uncertainty of this method even when 
vitreous humour hypoxanthine and urea are also analysed [105-107]. Use of CSF [98] and of 
synovial fluid [108] as alternatives to vitreous humour for potassium measurement have also been 
suggested, but to no avail. There are reports of immunochemical detection of glucagon in 
pancreatic cells and of calcitonin in thyroid c-cells being used to indicate time of death, but these 
methods are experimental at best [109,110]. The rate of loss of albumin from CSF has also been 
suggested for use in time of death estimation [111], but this approach would seem impractical. 
8. Sepsis 
Sepsis is complex condition that is often difficult to diagnose and treat, reflecting in part the lack of 
universally-applicable biomarkers for early diagnosis [112]. After death the clinical history and 
analysis of any specimens obtained in life is of course important in establishing the diagnosis. 
However, such information may be either incomplete, or unavailable. In such cases serial 
monitoring of serum C-reactive protein (CRP), procalcitonin, interleukin-6 (IL-6), interleukin-1β, 
soluble interleukin-2 receptor (sIL-2R), and lipopolysaccharide binding protein in the hours after 
death has been suggested as an aid to the postmortem diagnosis of sepsis, but has not been 
widely adopted [113;114]. Procalcitonin has a longer plasma half-life (25-30 h) and is more stable 
when compared to pro-inflammatory cytokines [115]. Recent preliminary studies have suggested 
that endocan (endothelial cell-specific molecule-1) and soluble triggering receptor expressed on 
myeloid cells-1 (sTREM-1) in serum derived postmortem from femoral blood and in pericardial and 
pleural fluid could be used in conjunction with procalcitonin, CRP, and sIL-2R as additional sepsis 
markers [116,117]. 
9. Sudden Unexplained/Unexpected Death 
Sudden Unexpected Death in Infancy [SUDI, also known as Sudden Infant Death Syndrome 
(SIDS)], Sudden Unexplained Death in Epilepsy (SUDEP), and Sudden Arrhythmic Death 
Syndrome (SADS, also known as Sudden Adult Death Syndrome) are all recognised occurrences. 
In SUDI, an acute manifestation of an inborn error of metabolism, particularly a fatty acid oxidation 
defect, has to be excluded. Guidance on biological samples required when investigating such 
deaths is given in Table 5. Markers of inflammatory response, including CRP, IL-6, and intercellular 
adhesion molecule-1 (ICAM-1) may be elevated in certain tissues after infections [118]. 
SADS cases are thought likely often to have a cardiac origin such as a fatal arrhythmia 
[119], but a full toxicological analysis is required to exclude recent use of not only illicit drugs such 
as cocaine and other stimulants, but also drugs given in therapy, for example antipsychotics and 
antidepressants, that may increase the risk of a fatal arrhythmia. Even if this is done, however, it is 
often impossible to state a precise cause of death with any degree of certainty. 
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 SUDEP is the leading cause of seizure-related mortality in people with epilepsy [121], but it 
not readily diagnosable except by a process of elimination. Factors may be non-adherence with 
anticonvulsant therapy (antiepileptic drugs, AEDs) or co-prescription of drugs such as tricyclic 
antidepressants and clozapine that may lower the seizure threshold. It has been suggested that 
plasma prolactin could indicate recent seizure activity/status epilepticus, but it has been found that 
this is not a reliable diagnostic marker [122]. 
Conclusions 
Biochemical analyses using primarily postmortem blood (or serum if available) and vitreous 
humour are now an accepted part of the investigation of possible alcohol- and diabetes-related 
deaths, and deaths that may have resulted from anaphylactic shock, from drowning, and from 
hypothermia. In large part this is because not only is vitreous humour less affected by postmortem 
changes than blood, but also the sample obtained is amenable to analysis using standard clinical 
chemistry methods designed for use with plasma or serum. Nevertheless many problems remain, 
such as assessing the role of exogenous potassium or insulin in a death, and estimating the time 
of death simply from postmortem changes in body biochemistry. For additional tests to gain 
widespread acceptance not only will there need to be extensive research and evaluation of the 
proposed test, but also the necessary methodology will need to be readily usable in clinical and/or 
forensic laboratories. 
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Table 1. Some laboratory investigations in life that may arouse or confirm a suspicion of 
poisoning 
Investigation Fluid Possible cause of increase Possible cause of 
decrease 
Anion gap ([Na+]+[K+]) 
– ([HCO3–]+[Cl–]) 
Plasma Ethanol, ethylene glycol, iron salts, 
isoniazid, methanol, metformin, 
paraldehyde, salicylates, toluene 
(chronic) 
- 
Calcium Plasma or 
serum 
- Ethylene glycol, fluorides, 
magnesium salts 
Chloride Plasma Bromide or organobromines (actually 
interference in method) 
- 
D-Glucose Blood  or 
fluoride/ 
oxalate 
plasma  
Salicylates, theophylline Ethanol (especially 
children), insulin, 
salicylates, sulfonylureas, 
valproate 
International 
normalized ratio (INR, 
prothrombin time) 
Blood Anticoagulant rodenticides (warfarin, 
bromdifacoum), paracetamol (early 
marker of hepatic damage) 
- 
Lactate Plasma Glycolate (from ethylene glycol, artefact 
on some blood gas and other 
analysers) 
- 
Magnesium Plasma or 
serum 
Magnesium salts - 
Osmolar gap # Plasma Acetone, ethanol, ethylene glycol, 
methanol, 2-propanol, hypertonic i.v. 
solutions (e.g. mannitol) 
- 
Potassium Plasma  Digoxin, potassium salts Diuretics, laxatives (both 
chronic), insulin, 
salbutamol, sulfonylureas, 
theophylline 
Sodium Plasma or 
serum 
MDMA (malignant hyperthermia) *, 
sodium salts 
Diuretics, water 
intoxication (acute and 
chronic), MDMA (very 
rare) 
* Methylenedioxymetamfetamine 
# Measured osmolality (freezing point depression) - calculated osmolality. Calculated osmolality = 2([Na+]+ 
[K+]) + urea + glucose (all mmol/L)  
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Table 2. Postmortem biochemistry: Some little used/unvalidated tests  
 
Analyte Matrix Suggested diagnostic role [References] 
Adrenaline:noradrenaline ratio Urine Hypothermia [4] 
Ammonia Vitreous humour Liver failure; time of death estimation  [5] 
Calcium Vitreous humour No clear role; does not relate to antemortem serum 
calcium 
Carbohydrate-deficient 
transferrin (CDT) 
Blood, vitreous 
humour 
Chronic alcohol use [6,7] 
Chymase activity Blood Anaphylactic shock [8] 
Chromogranin A Serum, 
cerebrospinal fluid 
Hypothermia [9] 
C-Reactive protein (CRP) EDTA blood, liver Recent infection (bacterial, viral, fungal, 
mycobacterial), trauma, burns, ketoacidosis, tissue 
necrosis (myocardial infarction, pancreatitis), 
inflammatory diseases, malignancy. Suggested 
role in diagnosis of sepsis if measured soon after 
death [10,11] 
Creatine kinase brain (CK-BB) CSF Diffuse brain injury/cerebral hypoxia 
Creatine kinase-muscle brain 
(CK-MB) 
Pericardial fluid Myocardial damage 
Ethyl glucuronide (EtG) and 
ethyl sulfate (EtS) 
Vitreous humour, 
urine 
Antemortem ingestion of ethanol [12,13] 
Free fatty acids Blood Hypothermia [14] 
Fructosamine Vitreous humour Diabetic ketoacidosis [15,16] 
Glucocorticoids Blood Hypothermia [17] 
Hypoxanthine Vitreous humour Time of death [18] 
L-Lactate Vitreous humour If very high may indicate lactic acidaemia, but may 
be formed perimortem [19] and increases after 
death  
Myoglobin Blood, urine Hyperthermia [20] 
Neurone specific enolase CSF Diffuse brain injury/cerebral hypoxia 
Osmolality Vitreous humour No clear role; increases with postmortem interval 
Thryoglobulin, free triiodo-
thyronine (T3) 
Blood Neck trauma, e.g. strangulation [21,22] 
Troponin Pericardial fluid Myocardial damage present prior to microscopic 
changes [23] 
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Table 3. Sample requirements: General postmortem biochemistry and toxicology1 
Sample Notes(1) 
Heart whole blood (right ventricle) 20 mL unpreserved (qualitative toxicology only) 
Jugular vein whole blood 20 mL unpreserved (qualitative toxicology only) 
Peripheral whole blood 20 mL from femoral or other peripheral site ensuring no 
contamination from urine or from central or cavity blood. Collect one 
portion into 2 % w/v sodium fluoride and another into a plain tube 
Urine 20-50 mL if available (plain tube, no preservative unless a portion 
required for ethanol measurement) 
Gastric contents(2) 25-50 mL (plain bottle, no preservative) 
Vitreous humour Maximum available, plain tube, separate specimens from both eyes if 
feasible. Collect one portion into 2 % w/v sodium fluoride if for 
ethanol measurement 
Cerebrospinal fluid 5-10 mL, plain tube 
Pericardial fluid Maximum available, plain tube 
Synovial fluid(3) Maximum available, plain tube 
Liver and other tissues Liver 10 g (deep inside right lobe), other tissues 10 g as appropriate 
Scene residues(4) As appropriate 
 
Key    (1) Smaller volumes may often be acceptable, for example in the case of young children 
 (2) Includes vomit, gastric lavage (stomach washout, first sample), etc. 
 (3) Alternative if vitreous humour not available 
 (4) Tablet bottles, drinks containers, aerosol canisters, etc. - pack entirely separately from 
biological samples, especially if poisoning with volatiles is a possibility 
 
                                               
1
 See Dinis-Oliveira et al. [24] for detailed discussion on samples and sampling with especial 
reference to forensic toxicology 
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Table 4. Postmortem biochemistry: Interpretation of results 
Analyte Matrix Typical reference range Interpretation of raised concentration 
Acetone1 Blood <2.5 mg/L Fasting, prolonged alcohol abuse, diabetic 
ketoacidosis, stress response (e.g. 
hypothermia) 
Chloride  Vitreous 
humour* 
105–135 mmol/L Sodium chloride poisoning; salt water 
drowning; dehydration (interpret in conjunction 
with creatinine and urea) 
Creatinine Vitreous 
humour* 
<115 µmol/L 
 
Poor renal function; high protein intake; large 
muscle mass; heat shock 
D-Glucose Vitreous 
humour* 
After death vitreous humour 
(and CSF) glucose falls 
rapidly therefore any 
detectable glucose requires 
investigation 
(Drug induced) hyperglycaemia, diabetic 
ketoacidosis, stress response (interpret in 
conjunction with lactate) 
Haemoglobin 
A1c (HbA1c) 
Blood <39 mmol/mol Hb Poor long term (8–12 weeks) blood glucose 
control 
β-Hydroxy-
butyrate 
(BHB) 
Blood, 
vitreous 
humour* 
0.1–1.0 mmol/L 
(pathologically significant 
>2.5 mmol/L) 
Fasting, prolonged alcohol abuse, diabetic 
ketoacidosis, stress response (e.g. 
hypothermia) 
L-Lactate Vitreous 
humour* 
<10 mmol/L Interpret in conjunction with vitreous glucose 
and postmortem interval 
Potassium Vitreous 
humour* 
After death vitreous 
potassium increases rapidly. 
Concentrations >15 mmol/L 
suggest postmortem 
decomposition 
Postmortem decomposition, little interpretative 
value. 
Sodium  Vitreous 
humour* 
135–145 mmol/L Sodium chloride poisoning; salt water 
drowning; dehydration (interpret in conjunction 
with vitreous creatinine and urea) 
Tryptase Blood <100 µmol/L Anaphylactic shock 
Urea Vitreous 
humour* 
 <10 mmol/L  Renal function; upper GI haemorrhage 
* See Rose and Collins [31] 
 
                                               
1
 Acetone not often measured; normally detected sometimes with other ketones and alcohols  such as 
butanone and propanol during blood/urine ethanol analysis by gas chromatography 
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Table 5. Some biological samples required when investigating Sudden Unexpected Death in 
Infancy [120] 
Sample (volume) Handling  Test 
Blood or serum (1–2 
mL) 
Centrifuge, store serum at –20 oC Toxicology 
Urine (20 mL if possible) Store –20 oC Toxicology and specialised tests for 
inherited metabolic diseases  
Blood from Guthrie card Normal (ensure circle is filled). Do 
not put in plastic bag 
Tests for inherited metabolic diseases 
Skin biopsy After discussion with paediatrician Tests for inherited metabolic disease, 
e.g. fibroblast enzyme activity 
Muscle biopsy After discussion with paediatrician If history suggests mitochondrial 
disorder 
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Figure 1. Interpretation of raised vitreous humour glucose and blood β-hydroxybutyrate 
(BHB) concentrations 
 
 
 
No Yes 
No 
Yes 
Yes No 
Yes 
No Yes 
Blood HbA1c >67 mmol/mol Hb  
Vitreous glucose detectable 
Blood acetone/BHB elevated 
Blood acetone/BHB elevated 
Hyperosmolar  
hyperglycaemic 
syndrome (HSS)* 
Non-diabetic hyper- 
glycaemia or hypothermia ? 
Non-diabetic ketoacidosis, but 
cannot exclude hypoglycaemia 
or hypothermia 
Hypoglycaemia due to e.g. 
insulin or acute ethanol 
poisoning? 
No 
* Requires confirmation from vitreous humour sodium and urea/creatinine 
Blood acetone/BHB elevated 
Diabetic  
hyperglycaemia/ 
ketoacidosis 
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• Biochemical analysis of postmortem specimens may sometimes aid death investigation  
• Assays can often be performed with due precaution using clinical chemistry systems 
• Vitreous humour  may be less affected by autolysis or microbial growth than blood 
• Results interpretation is often complicated because of the lack of reference ranges 
 
